Abstract:OBJECTIVE:To investigate the clinical effect and safety of heparin in treating fetal growth restriction (FGR). METHODS:A total of 107 women diagnosed with FGR were randomized into three groups. Group 1 (standard heparin group, n = 37) received 50 - 75 mg standard heparin added to 500 ml 5% glucose sodium chloride, infused intravenously in 6 - 8 hours. Group 2 (low molecular weight heparin group, n = 31) received 0.2 - 0.4 ml low molecular weight heparin given by subcutaneous injection. Control group (n = 39) received 20 ml dan-shen added to 500 ml low-molecular-weight dextran infused intravenously. Fetal growth indices, biophysical score, umbilical artery blood flow, count of platelet (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), 1-minute Apgar score, body weight and gestational age of the neonates were measured. Babies prognosis was followed-up. RESULTS:(1) Height of fundus of uterus was obviously increased per week in the groups of standard heparin (0.7 +/- 0.6) cm and low molecular weight heparin [(0.7 +/- 0.6) cm]] vs. control group [(0.5 +/- 0.4) cm, P < 0.05]. Biparietal diameter of fetus increased in standard heparin [(2.4 +/- 0.7) mm] and low molecular weight heparin [(2.5 +/- 0.8) mm] groups vs. control [(1.7 +/- 0.6) mm, P < 0.05]. The femur length, head circumference and abdominal circumference of fetus were significantly longer in heparin treated patients than in control group (P < 0.05). (2) Biophysical score improved in groups of standard heparin (9.7 +/- 0.8) and low molecular weight heparin (9.6 +/- 0.6) vs. control group (8.9 +/- 0.7) (P < 0.05). (3) Umbilical blood S/D ratio decreased in standard heparin (2.5 +/- 0.5) and low molecular weight heparin (2.4 +/- 0.5) groups vs. control group (2.9 +/- 0.6) (P < 0.05). Pulsatile index (PI) and resistance index (RI) were significantly lower also (P < 0.05).(4) Rate of one minute Apgar score (8 - 10) was 86% in group 1, 87% in group 2 and 74% in control group, respectively. Body weight of the neonates was significantly increased in group 1(3100 +/- 256 g) and in group 2 [(3080 +/- 225) g] vs. [(2580 +/- 304) g] in control group (P < 0.05). Gestational age was prolonged in group 1 [(38 +/- 3) w] and group 2 [(38 +/- 4) w] vs. control group [(37 +/- 4) w, P < 0.05]. (5) Incidence of term small for gestational age infant in groups of standard heparin and low molecular weight heparin was 5% and 6%, respectively, significantly lower than those in the control group (18%) (P < 0.05). (6) No difference was shown in PLT, PT and APTT before and after heparin treatment (P > 0.05). (7) There was no difference in fetal growth indices, biophysical score, umbilical blood, neonatal outcome between standard heparin and low molecular heparin groups. CONCLUSIONS:Heparin can improve placenta function and obviously increase body weight of fetuses and neonates. It is safe for both pregnant women and their fetuses.

The clinical observation of the effectiveness of hyperbaric oxygen binding routine method in the treatment of intrauterine growth retardation.

Effects of hyperbaric oxygen on plasma endothelin and nitric oxide in patients with intrauterine growth retardation

Clinical Observation of Tai'an Mixture on 42 Cases of Intrauterine Growth Restriction

[An Experimental Study on the Treatment of Fetal Rabbits with Intrauterine Growth Retardation].

Effect of L-arginine Treatment on Fetal Umbilical Artery Flow in Intrauterine Growth Retardation

[A Study on the Relationship Between Insulin-Like Growth Factor, Insulin-Like Growth Factor-Binding Protein-3 and Fetal Growth Retardation].

Effect of Heparin on Fetal Growth Restriction

NIPPV:the Clinical Therapeutic Effectiveness in Pregnant Women with Pulmonary Edema and the Influence on Fetus

Effect of Integrated Intervention for Patients with Gestational Diabetes Mellitus Undergoing Predelivery Insulin Pump Intensive Therapy

Clinical Observation of the Hyperbaric Oxygenation in the Treatment of Neonates with Hypoxic Ischemic Encephalopahy

Clinical analysis on mechanical ventilation combined with inhaled nitric oxide in the treat-ment of persistent pulmonary hypertension of newborn

Effects of Carboprost Tromethamine Combined with Modified B-Lynch Sutura on Prognosis and Life Quality in Treatment of Patients with Refractory Uterine Inertia Postpartum Hemorrhage

Clinical Effects of Tetramethylpyrazine in the Treatment of Fetal Growth Restriction

[Investigation on treatment of fetal growth restriction by salvia injection combined with composite amino acid].

Effects of low-molecular weight heparin on the placental ultrastructure and VEGF expression in cases with fetal growth restriction

Analysis of pregnancy outcome of 112 cases oligohydramnios of late stage treated by venous transfusion

Effect of Hyperbaric Oxygen with Therapeutic Dose on Retina of Fetal or Neonatal Mice

A clinical observation of therapeutic effect of combined heparin for intrahepatic cholestasis of pregnancy

The Effects and Mechanism of L-arginine Treatment on Fetal Growth Restriction

Clinical research of fetus distress treated with hyperoxin liquid

[The Relationships of the Serum Concentrations of Insulin-Like Growth Factors in Fetal Rats with Intrauterine Growth Retardation].